Due to a change in the classification of insulin, the door for biosimilars to insulin products was opened up in the US, which allowed for the first biosimilar to be approved midway through last year.

Despite all that, an allegation of witness tampering surfaced midway through the proceedings. A defendant scheduled for trial in August approached a government witness who was due to testify against ...

Spring is almost here and that means amusement parks are preparing for another season. Several of the beloved attractions in central Pennsylvania are adding new features or rides this season, so ...